Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 13Nausea 11Neoplasms 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Multiple Myeloma 2Lung Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Radiation Injuries 1Pancreatic Neoplasms 1Pain 1Neoplasms, Germ Cell and Embryonal 1Nausea With Vomiting Chemotherapy-Induced 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Neoplasms 1Hematologic Diseases 1Glioma 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1

Interventions

Palonosetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nausea With Vomiting Chemotherapy-Induced × Palonosetron × Clear all
NCT04592198 2025-03-24

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

Xiamen LP Pharmaceutical Co., Ltd

Phase 2 Completed
22 enrolled 8 charts

Nausea With Vomiting Chemotherapy-Induced

Data powered by HemOnc (CC BY 4.0) Colophon âš¡